Health Bulletin 27/June/2022

Here are the top health stories for the day :

Medical Council suspends doctor for negligence in knee replacement surgery      

 Holding a Karnataka-based doctor guilty of using poor-quality implants in a knee-replacement surgery and failing to provide post-operative care, the State Medical Council in Karnataka on June 4 has suspended his licence for a period of six months.

After Dr. Mohammed Irshad operated on the patient five years ago, the patient ultimately became bedridden and ultimately died on April 21 last year.

For more details, check out the full story on the link below:

Medical Council Suspends Doctor For Negligence In Knee Replacement Surgery 

CDSCO issues medical device alert for Cordis Palmaz Genesis Peripheral Stent   

In line with the Risk Assessment Form released by Cordis Cashel, Ireland, the Central Drugs Standard Control Organization (CDSCO) has issued a Medical Device Alert for PALMAZ GENESIS Peripheral Stent on OPTA PRO .035" Delivery System (PG2990PPX-82178943, PG2990PPX-82211305, PG3990PPS-82182764, PG3990PPX-82212989, PG3990PPX- 82218097).

This Medical Device Alert comes after Cordis released Distributed Product Risk Assessment Form dated 18.05.2022 indicating increased complaint rate for stent dislodgement.

For more details check out the full story on the link below:

CDSCO Issues Medical Device Alert For Cordis Palmaz Genesis Peripheral Stent

 Delhi HC relief to Intas- Stops two pharma companies from violating trademark of LOOZ    

The Delhi High Court has permanently restrained two pharmaceutical manufacturers from using the trademark 'LOOZOUT' in their products, which is deceptively similar to the registered trademark 'LOOZ'.

A single bench of Justice Jyoti Singh, while dealing with the suit moved by Intas Pharmaceuticals, also imposed a cost of Rs two lakh to the defendant companies.

As per the recently passed order, apart from permanently restraining them from manufacturing, selling, offering for sale, advertising, and promoting the products using the mark 'LOOZOUT', they are also stopped from manufacturing and selling products under any other mark, which is identical or deceptively similar to the registered mark of the Plaintiff 'LOOZ'.

For more details check out the full story on the link below:

Delhi HC Relief To Intas- Stops Two Pharma Companies From Violating Trademark Of LOOZ